2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Heart Diseases
3
Vascular Diseases
2
Small Cell Lung Carcinoma
2
Leukemia, Myeloid, Acute
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Cancer Resectable
1
Ovarian Carcinosarcoma
1
Noonan Syndrome 5
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Metabolic Diseases
1
Liver Neoplasms
1
Leukemia, Monocytic, Acute
1
Leukemia, Lymphoid
1
Immune-related Adverse Event
1
Hematologic Neoplasms
1
Heart Failure
1
Esophageal Neoplasms
1
Early Hormone Receptor-positive Breast Cancer
1
Drug-Related Side Effects and Adverse Reactions
1
Colorectal Neoplasms
1
Interventions
Bevacizumab
19
Capecitabine
15
Oxaliplatin
11
Irinotecan
11
Cetuximab
11
Fluorouracil
10
Leucovorin
8
aflibercept
7
Panitumumab
6
trifluridine tipiracil drug combination
4
Nivolumab
4
sintilimab
3
regorafenib
3
Ipilimumab
3
Vemurafenib
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
HMPL-013
2
Folfox protocol
2
Drug Therapy
2
tremelimumab
1
spartalizumab
1
raltitrexed
1
pembrolizumab
1
monoclonal antibody YYB-101
1
masitinib
1
irinotecan sucrosofate
1
glucopyranosyl lipid-A
1
folfirinox
1
durvalumab
1
camrelizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colorectal Cancer Metastatic
×
Antineoplastic Agents
×
Clear all
NCT03923036
2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
2,000 enrolled